Table 1 Baseline characteristics
Included N = 100 | Unplanned delay n = 24 | Ineligible of curative treatment n = 26 | ||||
|---|---|---|---|---|---|---|
Median age (range) | 70 | (54–84) | 70.5 | (56–86) | 81 | (58–89) |
Age ≥ 75 years | 32 | (32%) | 9 | (38%) | 19 | (73%) |
Women | 63 | (63%) | 12 | (50%) | 13 | (50%) |
Stage I | 72 | (72%) | 16 | (67%) | 10 | (38%) |
Stage II | 20 | (20%) | 7 | (29%) | 8 | (31%) |
Stage III | 8 | (8%) | 1 | (4%) | 3 | (12%) |
Stage IV | 5 | (19%) | ||||
Surgery | 76 | (76%) | 15 | (63%) | ||
Curative radiotherapya | 8 | (8%) | 1 | (4%) | ||
Stereotactic radiotherapyb | 16 | (16%) | 8 | (33%) | ||
Palliative treatment | 12 | (46%) | ||||
NSCLC | 77 | (77%) | 18 | (75%) | 11 | (42%) |
SCLC | 6 | (6%) | 1 | (4%) | 2 | (8%) |
Another primary lung cancer | 5 | (5%) | 1 | (4%) | 1 | (4%) |
No tissue diagnosis | 12 | (12%) | 4 | (17%) | 12 | (46%) |